P110α is the main PI3K isoform functionally involved in multiple myeloma cell survival

被引:0
|
作者
Hofmann, C.
Steinbrunn, T.
Stuehmer, T.
Chatterjee, M.
Schmiedl, N.
Einsele, H.
Bargou, R. C.
机构
[1] Univ Hosp Warzburg, Wurzburg, Germany
[2] Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
来源
ONKOLOGIE | 2013年 / 36卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:214 / 214
页数:1
相关论文
共 50 条
  • [31] Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
    Zhang, Biqin
    Luk, Cheukyau
    Valadares, Joyce
    Aronis, Christos
    Foukas, Lazaros C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [32] Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α
    Gritsman, Kira
    Yuzugullu, Haluk
    Thanh Von
    Yan, Howard
    Clayton, Linda
    Fritsch, Christine
    Maira, Sauveur-Michel
    Hollingworth, Gregory
    Choi, Christine
    Khandan, Tulasi
    Paktinat, Mahnaz
    Okabe, Rachel O.
    Roberts, Thomas M.
    Zhao, Jean J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (04): : 1794 - 1809
  • [33] A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110γ Isoform in Medulloblastoma Cell Proliferation and Chemoresistance
    Guerreiro, Ana S.
    Fattet, Sarah
    Kulesza, Dorota W.
    Atamer, Abdullah
    Elsing, Alexandra N.
    Shalaby, Tarek
    Jackson, Shaun P.
    Schoenwaelder, Simone M.
    Grotzer, Michael A.
    Delattre, Olivier
    Arcaro, Alexandre
    [J]. MOLECULAR CANCER RESEARCH, 2011, 9 (07) : 925 - 935
  • [34] PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition
    Hua-Fu Zhao
    Jing Wang
    Hao-Ran Jiang
    Zhong-Ping Chen
    Shing-Shun Tony To
    [J]. Journal of Experimental & Clinical Cancer Research, 35
  • [35] The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis
    Utermark, Tamara
    Rao, Trisha
    Cheng, Hailing
    Wang, Qi
    Lee, Sang Hyun
    Wang, Zhigang C.
    Iglehart, J. Dirk
    Roberts, Thomas M.
    Muller, William J.
    Zhao, Jean J.
    [J]. GENES & DEVELOPMENT, 2012, 26 (14) : 1573 - 1586
  • [36] The p110δ isoform of PI3K modulates TLR4 signalling and is crucial for survival from endotoxin and Escherichia coli infection
    Okeke, Emeka
    Okwor, Ifeoma
    Jia, Ping
    Uzonna, Jude
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190
  • [37] PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition
    Zhao, Hua-Fu
    Wang, Jing
    Jiang, Hao-Ran
    Chen, Zhong-Ping
    To, Shing-Shun Tony
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [38] The PI3K p110δ controls T-cell development, differentiation and regulation
    Patton, D. T.
    Garcon, F.
    Okkenhaug, K.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 167 - 171
  • [39] PI3K p110β: More Tightly Controlled or Constitutively Active?
    Vogt, Peter K.
    [J]. MOLECULAR CELL, 2011, 41 (05) : 499 - 501
  • [40] Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110α
    Zunder, Eli R.
    Knight, Zachary A.
    Houseman, Benjamin T.
    Apsel, Beth
    Shokat, Kevan M.
    [J]. CANCER CELL, 2008, 14 (02) : 180 - 192